Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sania Jevtic

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Physical Review Letters|May 1, 2012
Maximally and minimally correlated states attainable within a closed evolving systemSania Jevtic, David Jennings, Terry Rudolph
Physical Review Letters|July 26, 2014
Quantum steering ellipsoidsSania Jevtic, Matthew Pusey, David Jennings, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 14, 2015
Exchange fluctuation theorem for correlated quantum systemsSania Jevtic, Terry Rudolph, David Jennings, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 27, 2021
Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcomaPolona Safaric Tepes, Danilo Segovia, Sania Jevtic, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Physical Review Letters|May 1, 2012
Maximally and minimally correlated states attainable within a closed evolving systemSania Jevtic, David Jennings, Terry Rudolph
Physical Review Letters|July 26, 2014
Quantum steering ellipsoidsSania Jevtic, Matthew Pusey, David Jennings, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 14, 2015
Exchange fluctuation theorem for correlated quantum systemsSania Jevtic, Terry Rudolph, David Jennings, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 27, 2021
Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcomaPolona Safaric Tepes, Danilo Segovia, Sania Jevtic, et al.
Pageof 1